Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast Cancer

NCT04999540 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Tucidinostat
DRUG: Fulvestrant

Sponsor

Guangdong Women and Children Hospital